FDA Orange Book · active-ingredient family
Desvenlafaxine succinate
Desvenlafaxine succinate is approved as 1 brand and 11 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:PRISTIQ · NDA 021992
1
Brand (NDA)
11
Generics (ANDA)
1
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet, extended release
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PRISTIQRLD×3 | PF PRISM CV | NDA 021992 | AB | Aug 20, 2014 |
Generic (ANDA) products (11)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DESVENLAFAXINE SUCCINATE×3 | YICHANG HUMANWELL | ANDA 220460 | AB | Mar 10, 2026 | |
| DESVENLAFAXINE SUCCINATE×2 | MACLEODS PHARMS LTD | ANDA 211427 | AB | Jan 15, 2025 | |
| DESVENLAFAXINE SUCCINATE×3 | RUBICON RESEARCH | ANDA 204028 | AB | Dec 07, 2023 | |
| DESVENLAFAXINE SUCCINATE×3 | ZYDUS PHARMS | ANDA 204020 | AB | Nov 30, 2022 | |
| DESVENLAFAXINE SUCCINATE×3 | LUPIN | ANDA 204172 | AB | Apr 13, 2022 | |
| DESVENLAFAXINE SUCCINATE×3 | YICHANG HUMANWELL | ANDA 210014 | AB | Oct 13, 2020 | |
| DESVENLAFAXINE SUCCINATE×2 | PLATINUM | ANDA 204805 | AB | May 07, 2019 | |
| DESVENLAFAXINE SUCCINATE×3 | ALEMBIC | ANDA 204003 | AB | Sep 14, 2018 | |
| DESVENLAFAXINE SUCCINATE×3 | ACTAVIS LABS FL | ANDA 204065 | AB | Jul 29, 2016 | |
| DESVENLAFAXINE SUCCINATE×3 | HIKMA | ANDA 204083 | AB | Feb 16, 2016 | |
| DESVENLAFAXINE SUCCINATE×2 | PHARMOBEDIENT | ANDA 204095 | — | Jun 29, 2015 |
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8269040 | Jul 05, 2027 | in 1 yr 1 mo | Substance |
Desvenlafaxine succinate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
